Intramolecularly quenched fluorogenic peptide substrates for human renin.

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• Human renin is a key enzyme in the renin-angiotensin-aldosterone system (RAAS), regulating blood pressure.
• Development of specific and sensitive assays for human renin is crucial for research and diagnostics.
• Previous substrates lacked sufficient specificity or sensitivity for continuous human renin assays.

Purpose of the Study:

• To synthesize and characterize novel fluorogenic peptide substrates for human renin.
• To establish a sensitive and continuous assay for quantifying human renin activity.
• To investigate the substrate specificity and optimal conditions for human renin hydrolysis.

Main Methods:

• Classical solution phase synthesis of six intramolecularly quenched fluorogenic peptides.
• Peptides designed based on angiotensinogen sequences (Phe8-His13, His6-His13, Tyr4-His13) with Abz/EDDnp labels.
• Enzyme inhibition assays using a specific transition-state analog to confirm renin specificity.

Main Results:

• Synthesized peptides showed selective hydrolysis of the Leu-Val bond by human renin.
• Resistant to hydrolysis by pig renin and cathepsin D, indicating high specificity.
• A sensitive continuous assay detected as low as 70 microGU of human renin using Abz-Phe-His-Leu-Val-Ile-His-EDDnp.
• Optimal hydrolysis pH for substrates was determined to be in the range of 4 to 6.

Conclusions:

• Novel fluorogenic peptide substrates are highly specific and sensitive for human renin.
• These substrates facilitate continuous and accurate measurement of human renin activity.
• The developed assay provides a valuable tool for research into RAAS-related conditions.